192 related articles for article (PubMed ID: 32616890)
1. ACTL6A suppresses p21
Shrestha S; Adhikary G; Xu W; Kandasamy S; Eckert RL
Oncogene; 2020 Sep; 39(36):5855-5866. PubMed ID: 32616890
[TBL] [Abstract][Full Text] [Related]
2. ACTL6A suppresses p21
Shrestha S; Adhikary G; Naselsky W; Xu W; Friedberg JS; Eckert RL
Oncogenesis; 2021 Oct; 10(10):70. PubMed ID: 34689163
[TBL] [Abstract][Full Text] [Related]
3. Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma.
Chang CY; Shipony Z; Lin SG; Kuo A; Xiong X; Loh KM; Greenleaf WJ; Crabtree GR
Mol Cell; 2021 Dec; 81(24):4964-4978.e8. PubMed ID: 34687603
[TBL] [Abstract][Full Text] [Related]
4. ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.
Xiao Y; Lin FT; Lin WC
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33408251
[TBL] [Abstract][Full Text] [Related]
5. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
6. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism.
Kuwahara Y; Charboneau A; Knudsen ES; Weissman BE
Cancer Res; 2010 Mar; 70(5):1854-65. PubMed ID: 20179200
[TBL] [Abstract][Full Text] [Related]
7. ACTL6a enforces the epidermal progenitor state by suppressing SWI/SNF-dependent induction of KLF4.
Bao X; Tang J; Lopez-Pajares V; Tao S; Qu K; Crabtree GR; Khavari PA
Cell Stem Cell; 2013 Feb; 12(2):193-203. PubMed ID: 23395444
[TBL] [Abstract][Full Text] [Related]
8. Actin-like 6A enhances the proliferative and invasive capacities of laryngeal squamous cell carcinoma by potentiating the activation of YAP signaling.
Dang Y; Zhang L; Wang X
J Bioenerg Biomembr; 2020 Dec; 52(6):453-463. PubMed ID: 33067739
[TBL] [Abstract][Full Text] [Related]
9. The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth.
Palazzo E; Kellett M; Cataisson C; Gormley A; Bible PW; Pietroni V; Radoja N; Hwang J; Blumenberg M; Yuspa SH; Morasso MI
Oncogene; 2016 Jun; 35(24):3114-24. PubMed ID: 26522723
[TBL] [Abstract][Full Text] [Related]
10. ACTL6A deficiency induces apoptosis through impairing DNA replication and inhibiting the ATR-Chk1 signaling in glioblastoma cells.
Hu X; Pei D; Ci M; Zhang G; Li B; Wang J; Shen Y; Zhai X; Liang P; Cui H
Biochem Biophys Res Commun; 2022 Apr; 599():148-155. PubMed ID: 35182941
[TBL] [Abstract][Full Text] [Related]
11. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
[TBL] [Abstract][Full Text] [Related]
12. ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.
Zeng Z; Yang H; Xiao S
BMC Cancer; 2018 Oct; 18(1):1020. PubMed ID: 30348114
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane induction of p21(Cip1) cyclin-dependent kinase inhibitor expression requires p53 and Sp1 transcription factors and is p53-dependent.
Chew YC; Adhikary G; Wilson GM; Xu W; Eckert RL
J Biol Chem; 2012 May; 287(20):16168-78. PubMed ID: 22427654
[TBL] [Abstract][Full Text] [Related]
14. The role of KLF4 in UVB-induced murine skin tumor development and its correlation with cyclin D1, p53, and p21(Waf1/Cip1) in epithelial tumors of the human skin.
Choi WJ; Youn SH; Back JH; Park S; Park EJ; Kim KJ; Park HR; Kim AL; Kim KH
Arch Dermatol Res; 2011 Apr; 303(3):191-200. PubMed ID: 21132436
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 knockdown up-regulates p53 and p21/Cip1 expression in renal adenocarcinoma cells but not in normal renal-derived cells in a deacetylase-independent manner.
Fujino T; Yokokawa R; Oshima T; Hayakawa M
J Toxicol Sci; 2018; 43(12):711-715. PubMed ID: 30518708
[TBL] [Abstract][Full Text] [Related]
16. FAK deletion promotes p53-mediated induction of p21, DNA-damage responses and radio-resistance in advanced squamous cancer cells.
Graham K; Moran-Jones K; Sansom OJ; Brunton VG; Frame MC
PLoS One; 2011; 6(12):e27806. PubMed ID: 22194793
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional inhibition of p21WAF1/CIP1 gene (CDKN1) expression by survivin is at least partially p53-dependent: evidence for survivin acting as a transcription factor or co-factor.
Tang L; Ling X; Liu W; Das GM; Li F
Biochem Biophys Res Commun; 2012 May; 421(2):249-254. PubMed ID: 22503977
[TBL] [Abstract][Full Text] [Related]
18. Sp1 regulates Raf/MEK/ERK-induced p21(CIP1) transcription in TP53-mutated cancer cells.
Karkhanis M; Park JI
Cell Signal; 2015 Mar; 27(3):479-86. PubMed ID: 25595558
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells.
Fang Z; Fu Y; Liang Y; Li Z; Zhang W; Jin J; Yang Y; Zha X
J Cell Biochem; 2007 Jun; 101(3):654-64. PubMed ID: 17211849
[TBL] [Abstract][Full Text] [Related]
20. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.
Zhang W; Geiman DE; Shields JM; Dang DT; Mahatan CS; Kaestner KH; Biggs JR; Kraft AS; Yang VW
J Biol Chem; 2000 Jun; 275(24):18391-8. PubMed ID: 10749849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
